Notably, D-PROTAC also elicits downregulation of various downstream target genes regulated by STAT3, resulting in cell cycle arrest, apoptosis promotion, inhibition of tumor migration and proliferation, and suppression of tumor immune evasion. The gene discussed is STAT3; the disease is neoplasm.